The committee of Vietnam Pharmacopoeia have been established since July 1963. Mission is to build a pharmacopoeia. Its content comprises national standards of quality for domestic drugs. Committee have been organized compilation and publication of Vietnamese Pharmacopoeia No I including 2 volume: volume I (1971), Volume II (1983). Vietnamese Pharmacopoeia NoII including volume I (1990), Volume II (1991), Volume III (1994). Supplemental volume comprise 32 standards about vaccine and vaccine test methods.
Pharmacopoeias ; Pharmacy

Study quality of 10 tapioca starch samples, which were used to make excipient pill in some medicine enterprises in Ha Noi and Central area based on of standard II part 3 of Vietnam pharmacopoeia and 24 America pharmacopoeia. Result showed: most of tapioca starch that used to make excipient in the enterprises had low quality. The study constructed elaboration of refinement method for jambose tapioca starch come up to starch of jambose standard of America pharmacopoiea 24. Base on the process of purify tapioca starch can purify tapioca starch with big size and get to high quality.
Starch ; Excipients ; Pharmacopoeias

The material is seeds of Delavaya toxocarpa French harvested in Cao Bang province in 1999, 2000 and 2001. Fatty oil was quantified by weighing method. The indices of fatty oil were identified in relation to Vietnamese Pharmacopoeia. The fatty acid ingredients were analysed by gas chromatography (GC). The results showed that the fatty oil content in Delavaya toxocarpa French seeds was high (39.63+/-0.836), acidic index was 37.651+/-0.836, iodine index was 69.615+/-1.076, soap index was 180.762+/-3.382. The fatty oil included palmitic, oleic, linoleic, stearic, gadoleic and arachidic acids. Among these, oleic and gadoleic acids had the highest content
Oils ; Seeds ; Pharmacopoeias

(1) Some salient results attained: supply drug for people, manufacture, circulation, raising quality of drug; using safely sensibly drug; Strengthen governmental management task of drug, strengthen education. (2) challenges: organizational, realization ability of Party, Governmental policy have remainly limited. Health budget has not increased; Influence of market mechanism; Balance between preventive task and treatment
Public Policy ; Pharmacopoeias

OBJECTIVEEnable to make the origin of some medicinal materials from animals-national-standard Chinese Pharmacopoeia subdivision 1 more complete, to protect and utilize the wild medicinal animal resources, and to improve the quality of traditional Chinese medicines materials materials.

METHODIn accordance with author's over two decades of studies in medicinal material from animals and medicinal animals, combining with modern animal classification findings, comparing the contents of medicinal material origin from animals in Pharmacopoeia new edition.

RESULTGive amendment advices on gallnut, concha arcae, zaocys dhumnade, gadfly, and so forth the fifteen kinds of medicinal material origin from animals' taxonomic status, Chinese names and their Latin scientific names.

CONCLUSIONThe origin of accuracy of medicinal material origin from animals is critical to ensure the quality of traditional Chinese medicine. As a national-level traditional Chinese medicine code of laws, it should advance with times, actively absorb and adopt the latest achievements in scientific research. Meanwhile, modern molecular biology techniques should be used to develop the research of conventional medicinal material origin from animals in a planned and systematic manner.

Term of medicinal materials and decoction pieces in Chinese pharmacopoeia (2010 edition, Volume I) have been analyzed and d. 374 among 593 medicinal materials in Chinese pharmacopoeia has determination term including 461 determination indexes, 323 compositions and 9 s; 417 kinds of decoction pieces among 822 in Chinese pharmacopoeia has determination term. Eight kinds of decoction pieces with limit requirements were found with no determination term. Content and style of term of and cutting crude drugs were inconsistent. Suggestions related have also been given for pharmacopoeia revision.
Drugs, Chinese Herbal ; Medicine, Chinese Traditional ; Pharmacopoeias as Topic

To better standardize clinical standard of medicinal materials and cut crude drugs in Chinese Pharmacopoeia (2010 edition, Volume I) and finish compiling work of relevant matching book named Clinical Guide to the Chinese Pharmacopoeia, based on analyzing the problems in clinical standard of medicinal materials and cut crude drugs in Chinese Pharmacopoeia (2005 edition, Volume I), feasibly practicable revising suggestion of standardizing clinical standard of medicinal materials and cut crude drugs in Chinese Pharmacopoeia (2010 edition, Volume I) is proposed.
China ; Drug and Narcotic Control ; Drugs, Chinese Herbal ; standards ; Pharmacopoeias as Topic

Based on the Chinese pharmacopeia 2000 ed and Japanese pharmacopeia 14st ed., the original plant differencesof Chinese raditional medicines and Japanese Kampo medicines were compared by making list. The differences and reasons were analyzed.
China ; Drugs, Chinese Herbal ; Japan ; Medicine, Chinese Traditional ; Medicine, Kampo ; Pharmacopoeias as Topic ; Plants, Medicinal

Because of many reasons, big changes occur in the varieties of ancient and modern Chinese herbs. Besides a significant increase in the number, there are many other features, such as significant differences among mainstream varieties, partly resolving the chaotic situation of uncoincidence of different herb names, increasing proportion of plant herbs, and herbal multi-polarization, etc.
China ; Drugs, Chinese Herbal ; classification ; history ; History, Ancient ; Pharmacopoeias as Topic ; history ; Plants, Medicinal ; classification

The improvement of the harvest period standards is critical in the quality control of Chinese medicinal materials. The present study statistically analyzed the harvest period standards of plant medicinal materials in the 2020 edition of Chinese Pharmacopoeia(Vol.Ⅰ) and put forward the existing problems and suggestions based on herbal records and modern research to provide references for the improvement of the standards. According to the statistical analysis, in 499 types of plant medicinal materials, harvest period standards are recorded under 486 types, accounting for 97.4%, and are lacking in the remaining. Only one medicinal material(Stellariae Radix) is recorded with the standard of the harvest year. The standards of the harvest season and phenological period are recorded under 233 types, accounting for 46.7%. For 237 types, only harvest season is specified, accounting for 47.5%, and for 15 types, only harvest phenological period is specified, accounting for 3.0%. Among 222 types mainly derived from cultivation and 51 types from wild resources and cultivation, only 11 types are recorded with harvest period of cultivated products. Only Stellariae Radix is recorded with the harvest period standards for the wild and cultivated products separately. The harvest period standards of plant medicinal materials with different medicinal parts have certain rules to follow. The main problems about the harvest period standards are discovered. Specifically, no harvest period standards are recorded under 13 types of plant medicinal materials. Almost all perennial cultivated medicinal materials are not recorded with harvest year standard. No phenological period standard is found under 250 types of plant medicinal materials. There is no clear distinction between the harvest period standards of cultivated and wild products. The evidence for harvest period standards of 26 types of plant medicinal materials that can be harvested all year round is insufficient. As a result, it is proposed to strengthen basic research in response to the above-mentioned problems and improve the harvest period standards as soon as possible to ensure the quality of Chinese medicinal materials.
China ; Drugs, Chinese Herbal/standards* ; Medicine, Chinese Traditional ; Pharmacopoeias as Topic ; Plants, Medicinal ; Quality Control